Skip to content

Check the effect Of Virechana Karma (Purgation therapy) Followed by Shamana With orally administration of Laghumanjisthadi Decoction and External Application of Chakramarda beeja lepa in the Management of Dadru W.S.R To Ringworm.

To Evaluate The Efficacy Of Virechana Karma Followed By Shamana With Laghumanjisthadi Kwatha Orally And Chakramarda Beeja Lepa In The Management Of Dadru W.S.R To Dermatophytosis - An Open Labelled Clinical Study. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099114
Enrollment
15
Registered
2025-12-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Goverment Akhandanand Ayurveda College, Ahmedabad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Dignosed case of dadru ( ringworm) based on classical ayurvedic symptos. 2.Patient presenting with symptoms like kandu(itching), raga( redness), pidika(pimples)& mandalodbhav( raised patches) 3.Patient who are snehapana yogya and virechana yogya. 4.Patients willingly to undergo virechana karma and internal as well as external ayurvedic treatments. 5.Patients who are willingly to give informed written consent and follow the study protocol. 6.Patients with recurrent fungle infection history.

Exclusion criteria

Exclusion criteria: 1.Patients suffering from other types of skin diseases (e.g., K/C/O Psoriasis, Eczema, Leprosy, Scabies) that may interfere with assessment. 2. Patients who are Snehapana Ayogya & Virechana Ayogya 3. Patients with severe systemic illnesses like K/C/O uncontrolled Diabetes mellitus, tuberculosis, HIV/AIDS, hepatitis, or cardiac diseases, other infectious disease. 4. Pregnant and lactating women. 5. patients with K/C/O Psychiatric illness or non-cooperative attitude affecting protocol adherence.

Design outcomes

Primary

MeasureTime frame
Reduction in the symptoms of dadru kustha.Timepoint: 45 days

Secondary

MeasureTime frame
Improvement in the symptoms of dadru kustha.Timepoint: 45 days

Countries

India

Contacts

Public ContactVd Rohini Rakesh Salve

govt. akhandanand ayurvedic hospital Ahemdabad

rohinirakesh2@gmail.com9313001450

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026